Serum Institute of India obtains emergency use authorisation in India for AstraZeneca’s COVID-19 vaccine
AstraZeneca’s COVID-19 vaccine authorised in five other countries Company continues to seek further approvals around the worldAstraZeneca’s COVID-19 vaccine has been granted emergency use authorisation in India as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco for the active immunisation of adults. The vaccine was shown in clinical trials to be safe and effective at preventing symptomatic COVID-19, with no severe cases and no hospitalisations more than 14 days after the second dose. The approval in India is an important milestone as it will enable to supply